Trial Profile
A naturalistic, retrospective trial evaluating the efficacy of venlafaxine monotherapy and olanzapine augmentation in patients originally diagnosed as unipolar depression disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Venlafaxine (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- 08 Oct 2016 New trial record